SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-013599
Filing Date
2021-03-16
Accepted
2021-03-16 16:31:03
Documents
78
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cala-10k_20201231.htm   iXBRL 10-K 3036245
2 EX-23.1 cala-ex231_8.htm EX-23.1 3067
3 EX-31.1 cala-ex311_6.htm EX-31.1 16026
4 EX-31.2 cala-ex312_187.htm EX-31.2 16026
5 EX-32.1 cala-ex321_9.htm EX-32.1 8199
6 EX-32.2 cala-ex322_188.htm EX-32.2 8199
7 GRAPHIC gosisoiksqfh000001.jpg GRAPHIC 117863
  Complete submission text file 0001564590-21-013599.txt   10569017

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA cala-20201231.xsd EX-101.SCH 58595
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20201231_cal.xml EX-101.CAL 56922
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20201231_def.xml EX-101.DEF 181701
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20201231_lab.xml EX-101.LAB 471407
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20201231_pre.xml EX-101.PRE 369006
13 EXTRACTED XBRL INSTANCE DOCUMENT cala-10k_20201231_htm.xml XML 2036730
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36644 | Film No.: 21746214
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences